Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Most women with PCOS have high levels of male hormones, and free testosterone is the best marker for this.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Finasteride may cause slight depression and anxiety.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Lower SHBG levels may increase the risk of PCOS.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

A new gene, JMJD1C, may affect testosterone levels in men.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Prostaglandin D2 blocks new hair growth after skin injury through the Gpr44 receptor.